Mass spectrometry identifies and quantifies peptides by measuring the mass-to-charge ratio of intact peptide ions and their fragments, then matching those masses against sequence databases. Expect ESI or MALDI sources, Orbitrap or TOF analysers, and either DDA or DIA acquisition, depending on whether discovery depth or reproducible quantification takes priority. The parameters below cover what actually changes your results.
TL;DR:
- High-resolution Orbitrap analysers are indispensable for distinguishing modifications such as deamidation or PTMs, thanks to their superior mass accuracy.
- Sample preparation choices – digestion for bottom-up proteomics versus filtration for peptidomics – significantly shape data interpretation and the biological insight you can draw.
- The choice of ionisation method, ESI for LC-MS and MALDI for rapid fingerprinting, affects how sample complexity is handled and how sensitive the analysis is.
- Fragmentation strategies in tandem MS, such as CID/HCD or ETD/ECD, must match the modification of interest and the downstream database search to allow correct identification.
- Regular instrument calibration, verification of sample purity and sound QC practice are essential for reliable results in peptide mass spectrometry.
Table of contents
- What makes peptide mass spectrometry work
- Getting peptides ready for the instrument
- Ionisation and fragmentation: matching method to molecule
- Chromatography: getting the separation right before the MS even sees the sample
- Choosing between DDA and DIA for peptide data acquisition
- From spectrum to sequence: identification and software considerations
- Where peptide mass spectrometry gets used
- A fast checklist for instrument and sample problems
- Why peptide purity verification changes your mass spec results
- Laboratory lessons and starter parameters
- Another way to source COA-verified peptides for your MS work
- Sources
What makes peptide mass spectrometry work
Every peptide MS measurement comes down to one number: the mass-to-charge ratio, m/z. A peptide ionised in the source picks up one or more protons, and the analyser reports the mass of that charged species divided by its charge state, not the peptide’s actual molecular weight. A tryptic peptide carrying two protons appears at roughly half the m/z you would expect from its neutral mass. Get the charge state wrong during data interpretation and the sequence is assigned completely incorrectly – a mistake that happens during manual spectrum review more often than most people admit.
The analyser you choose determines whether the difference between two similar peptides is visible at all. Three types dominate peptide analysis, and each earns its place for different reasons:
- Quadrupole analysers filter ions by m/z using oscillating electric fields. They are fast and robust but offer relatively low resolution, which is why they are usually combined with another analyser (as in a triple quadrupole or Q-Exactive hybrid) rather than used alone for peptide identification.
- Time-of-flight (TOF) analysers measure how long an ion takes to travel a fixed distance. They offer good speed and decent resolution, making them well suited to high-throughput screening where fast answers matter more than the finest mass accuracy.
- Orbitrap analysers trap ions in an electrostatic field and measure their oscillation frequency, which delivers the high resolution and mass accuracy that have made them the go-to choice in peptide proteomics.
Resolution and mass accuracy matter most when you need to tell apart peptides that almost overlap. Deamidation shifts peptide mass by about 0.98 Da – close enough that a low-resolution instrument reads it as noise or as a shoulder on the parent peak. An Orbitrap-class instrument resolves that difference cleanly, which is exactly why high-resolution platforms have become standard whenever PTM localisation or distinguishing isobaric peptides is the goal rather than a nice-to-have.
Getting peptides ready for the instrument
Sample preparation decisions at the bench determine what the instrument can and cannot tell you later. The two dominant workflows, bottom-up proteomics and peptidomics, split early and stay separate.
Bottom-up preparation follows a fairly standard sequence:
- Lyse cells or tissue to release proteins, usually with a detergent or a mechanical disruption method compatible with the subsequent digestion.
- Reduce disulfide bonds with DTT or TCEP, then alkylate free cysteines with iodoacetamide to prevent them from re-forming.
- Digest with trypsin (occasionally Lys-C or a combination) to generate peptides with predictable cleavage sites at lysine and arginine.
- Desalt the digest, typically by C18 solid-phase extraction, to remove salts and detergents that suppress ionisation.
Peptidomics skips step three entirely. Endogenous peptides made by the cells themselves carry biological information in their exact length and cleavage sites. Digesting the sample destroys that information, which is why peptidomics workflows rely on rapid heat or acid inactivation of proteases immediately after sampling, followed by size-exclusion or molecular-weight cut-off filtration rather than enzymatic treatment.
Enrichment steps become necessary when the target makes up only a small fraction of the total peptide pool. IMAC (immobilised metal ion affinity chromatography) enriches phosphopeptides via metal ions such as Fe3+ or Ti4+. TiO2 beads do something similar with different selectivity. Antibody-based enrichment suits specific PTMs such as acetyl-lysine, where generic chemical enrichment falls short.
Pro tip: Salt and detergent carryover is by far the most common cause of poor ESI sensitivity in a new lab. If peak intensities look flat and lifeless for no obvious reason, run a blank injection first. Ion suppression from residual SDS or Tris buffer masquerades as a “bad instrument day” far more often than genuine hardware problems do.
Ionisation and fragmentation: matching method to molecule
Electrospray ionisation dominates LC-MS peptide analysis for a practical reason: it couples directly to liquid chromatography. A peptide-containing solvent stream passes through a capillary emitter held at around 2 to 4 kV, producing charged droplets that shrink into gas-phase peptide ions as the solvent evaporates.
Voltage and flow rate in practice: ESI emitter voltage sits in the 2 to 4 kV range on most nanoLC setups, and lower flow rates are known to improve ionisation efficiency, because smaller droplets form more easily at low flow. That is the physical reason nanoLC outperforms analytical-flow HPLC for detecting peptides at trace levels.
MALDI takes a different route: peptides are embedded in a crystalline matrix, and a laser generates ions directly from a solid surface. The technique handles complex mixtures with less chromatography and tolerates some contaminants that ESI cannot, making it the workhorse for rapid peptide mass fingerprinting, although it is typically paired with TOF analysers rather than the Orbitrap platforms common in LC-MS workflows.
The choice of fragmentation method changes what becomes visible in the resulting MS/MS spectrum:
- CID/HCD (collision-induced and higher-energy collisional dissociation) breaks peptide backbones at the amide bonds, producing b and y ions. It is fast and works well for standard peptide identification, but it can strip labile PTMs such as phosphorylation from the backbone before useful sequence data are obtained.
- ETD/ECD (electron transfer and electron capture dissociation) fragments more gently, preserves labile modifications and produces c and z ions. That makes it the better choice when phosphorylation, glycosylation or other sensitive PTMs are the actual research question.
- EThcD, a hybrid approach, combines both to improve sequence coverage for larger or more heavily modified peptides.
Match the fragmentation method to the downstream search strategy before the run, not afterwards. A database search tuned for b/y ions scores c/z fragment spectra poorly, and mismatched settings are a quiet, common source of missed identifications.
Chromatography: getting the separation right before the MS even sees the sample
Flow rate is the first decision, and it shapes everything that follows. NanoLC at around 200 to 400 nanolitres per minute delivers the best sensitivity for limited or precious samples, because low flow rates concentrate the peptide signal in a smaller ESI plume. Microflow (a few microlitres per minute) trades some sensitivity for better retention time reproducibility and fewer column clogs, which is useful in clinical or high-throughput quantitative pipelines. Analytical flow rates in the hundreds of microlitres per minute sacrifice sensitivity almost entirely but tolerate dirtier samples and higher loading amounts.
Column choice follows the same logic:
- A 15 to 25 cm C18 reversed-phase column with 1.7 to 3 µm particles handles most standard bottom-up runs.
- Longer columns (25 to 50 cm) and shallower gradients (90 to 180 minutes) improve peptide separation for deep proteome coverage, at the cost of instrument time.
- Short columns and steep gradients (20 to 40 minutes) suit targeted or high-throughput screening, where depth matters less than speed.
Fractionation makes sense when a single LC-MS run cannot resolve enough peptides to cover a complex proteome. High-pH basic reversed-phase fractionation, which splits a digest into 8 to 12 fractions before a second, low-pH separation, is a straightforward way to roughly double the number of identifications for complex samples without changing instruments.
Choosing between DDA and DIA for peptide data acquisition
Data-dependent acquisition (DDA) selects the most intense precursor ions in real time and fragments them one after another. It is the classic discovery workflow and produces deep, flexible datasets, but it suffers from stochastic sampling. Run the same sample twice and you will not get identical peptide lists, because the instrument’s real-time selection logic makes slightly different decisions on each run.
Data-independent acquisition (DIA) fragments all precursors within defined m/z windows regardless of intensity, systematically and on every run. That trades some flexibility for reproducibility, which matters enormously in quantitative studies across many samples, where consistent peptide detection across a cohort is the whole point.
Quantification strategy is a decision separate from acquisition mode:
- Label-free quantification compares peak intensities or spectral counts across separately run samples. It is the cheapest and most flexible option but requires tight chromatographic reproducibility to avoid comparing apples with oranges.
- SILAC (stable isotope labelling by amino acids in cell culture) labels cells metabolically before mixing, so labelled and unlabelled peptides run in the same injection and are compared directly. It is limited to systems where the growth medium can be controlled, which rules out most clinical tissue.
- TMT (tandem mass tags) chemically labels peptides with isobaric tags after digestion, allowing up to 18 samples to be multiplexed in a single LC-MS run, which drastically cuts instrument time in large cohort studies.
Starting values for instrument settings worth knowing before you open the method editor: isolation windows of 1.2 to 2 Da for DDA, cycle times under 3 seconds to keep pace with chromatographic peak widths, and an MS1 resolution of around 60,000 to 120,000 and an MS2 resolution of around 15,000 to 30,000 on Orbitrap platforms. Narrower isolation windows improve selectivity but cost sensitivity for lower-abundance precursors.
From spectrum to sequence: identification and software considerations
Database searching remains the backbone of peptide identification. The software digests a reference proteome in silico, predicts theoretical fragment spectra for every candidate peptide and scores those predictions against the actual MS/MS data to find the best match.
False discovery rate control is not optional. Skip this step, or run a search without decoys, and you report identifications with no honest measure of how many of them are wrong.
A few points separate a clean workflow from a shaky one:
- Library-based DIA search strategies use a spectral library built in advance from earlier DDA runs, which improves sensitivity but assumes the library actually represents the sample type.
- Library-free DIA searches directly against a predicted or in-silico spectral library – more flexible, but sometimes less sensitive for unusual sample types.
- De novo sequencing, deriving the sequence directly from fragment mass differences without a database, matters for peptides that do not appear in any reference proteome, but it has higher error rates than database matching.
- PTM localisation scoring (tools such as AScore or similar site-localisation algorithms) is indispensable whenever a modification could sit on more than one residue of a peptide, because a high-confidence peptide ID with an uncertain PTM position is only half an answer.
Pro tip: Before reporting an identification, check for consistent detection across biological replicates and visually confirm the spectral match for anything that supports a key conclusion.
Where peptide mass spectrometry gets used
Peptidomics and bottom-up proteomics answer different biological questions, and that difference starts at the bench. Peptidomics captures endogenous peptides as biology made them, preserving exact cleavage sites with functional significance – for example, distinguishing an active hormone fragment from an inactive precursor. Bottom-up proteomics deliberately erases that information through digestion in order to maximise protein coverage instead.
PTM mapping studies typically combine ETD or EThcD fragmentation with IMAC or TiO2 enrichment when phosphorylation is the target, because gentle fragmentation preserves the modification long enough to localise it. Glycosylation studies often add specific glycosidase treatments before MS to simplify the resulting spectra.
Quantitative peptide studies stand or fall on experimental design decisions made long before the instrument run:
- Plan at least three biological replicates per condition to distinguish real changes from normal variability.
- Spike in a known amount of a synthetic peptide standard to normalise across runs and detect systematic drift.
- Randomise the injection order across conditions so that time-dependent instrument drift is not mistaken for a genuine biological effect.
A fast checklist for instrument and sample problems
Low identification numbers and messy chromatograms almost always trace back to a handful of causes, and working through them in the right order saves time.
- Check mass calibration first. Drifting calibration silently degrades every downstream ID; run a calibration standard and confirm mass accuracy is within the manufacturer’s stated tolerance before investigating anything else.
- Look for contamination. Polymer peaks (from plastic tubes or pipette tips), keratin (from skin or hair) and detergent carryover are the usual suspects behind a mysterious loss of sensitivity.
- Inspect the chromatogram directly. Peak tailing usually points to a degraded column or a dead-volume problem in the fittings; software for automated peak deconvolution can help extract a clean quantitative signal from overlapping or poorly resolved peaks.
- Repeat sample preparation from an earlier step if digestion efficiency looks incomplete (unusually many missed cleavages), rather than trying to compensate through search parameters.
Pro tip: Keep a reference peptide mix exclusively for instrument QC, run it at the start of every session and log retention time and peak shape over time. A slow creep in retention time is often the earliest warning sign of a column that needs replacing – long before it shows up as a drop in identification numbers.
Why peptide purity verification changes your mass spec results
A contaminated or misidentified starting peptide poisons every downstream measurement, and it is a more common source of error than most published methods sections acknowledge.
That is the practical reason a verifiable, batch-specific certificate of analysis (COA) counts for more than a supplier’s word. When sourcing a peptide as an internal standard or spike-in for quantitative MS work, ask for:
- The actual HPLC chromatogram, not just a summary purity percentage.
- Batch-specific testing rather than a generic certificate for the product line.
- Mass confirmation data alongside the purity figure, because a peptide can be chemically pure and still have the wrong mass if an error occurred during synthesis.
Peptélia’s quality testing documentation sets out exactly what is verified before a batch ships – which matters when a reviewer eventually asks how you know the standard was what the label claimed.
Laboratory lessons and starter parameters
When setting up a new peptide MS method, start with an ESI voltage of around 2 to 3.5 kV and a nanoLC flow of around 200 to 400 nl/min. As a sensible default, set MS1 resolution to 60,000 and MS2 resolution to 15,000 to 30,000, then adjust to the requirements of the specific peptides.
Three habits pay off more than any single parameter tweak. Run a QC standard at the start of every batch, not only once something already looks wrong. Keep a running log of retention times for a fixed reference peptide so you can spot drift before it ruins an entire experiment. And never trust a purity claim that cannot be traced back to an actual chromatogram.
Plan the acquisition strategy, DDA or DIA, and the fragmentation method before sample preparation begins, because those downstream decisions should determine how you enrich and digest, not the other way round.
— Max
Another way to source COA-verified peptides for your MS work
If you are building a quantification standard curve or need a clean reference peptide for method validation, sourcing reliable starting material matters as much as the instrument settings.
This documentation is directly relevant to MS work: a verified reference standard removes a whole category of uncertainty when deciding whether a strange peak is a genuine biological signal or a contaminated starting reagent. Peptélia ships from the EU with a batch-specific COA and HPLC data, available for products such as Selank and TB-500. The full catalogue lets you review the purity documentation for the peptide you need before ordering.
Sources
- A beginner’s guide to mass spectrometry–based proteomics
- Identifying and Measuring Endogenous Peptides through Peptidomics
